HRA Pharma investigational site 1016 — Clarksville, Tennessee

HRA Pharma investigational site 1016 is a clinical research site located in Clarksville, Tennessee, United States 37043.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

HRA Pharma investigational site 1016 has participated in 1 clinical trials.

Therapeutic areas: Contraception.

Sponsors: HRA Pharma.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Clarksville

Browse all research sites in Tennessee · View every site in Clarksville

• GSK Investigational Site
• Alpha Clinical Research
• Research Site
• Premier Medical Group
• Innovative Clinical Research
• Akero Clinical Study Site
• Duramed Investigational Site
• Pfizer Investigational Site
• Premier Research
• 89bio Clinical Trial Site
• Premier Medical Group - Clarksville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for HRA Pharma investigational site 1016?

HRA Pharma investigational site 1016 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has HRA Pharma investigational site 1016 conducted?

HRA Pharma investigational site 1016 has 1 clinical trials on record. Their work covers Contraception.

Is HRA Pharma investigational site 1016 accredited by Crixeo Clinical Trials?

HRA Pharma investigational site 1016 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about HRA Pharma investigational site 1016?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.